Inhibikase Therapeutics Inc (IKT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 63k | 65k | 116k | 80k | 0 | 0 | 0 | 0 |
| Operating Income | -4.34M | -4.72M | -6.2M | -4.77M | -4.4M | -4.78M | -5.05M | -5.83M |
| Pre Tax Income | -4.28M | -4.48M | -5.78M | -4.6M | -4.18M | -4.65M | -4.96M | -5.78M |
| Net Income | -4.28M | -4.48M | -5.78M | -4.6M | -4.18M | -4.65M | -4.96M | -5.78M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -4.34M | -4.72M | -6.2M | -4.77M | -4.4M | -4.78M | -5.05M | -5.83M |
| EBITDA | -4.33M | -4.71M | -6.04M | -4.76M | -4.4M | -4.78M | -5.05M | -5.82M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.04M | 1.12M | 698k | 3.1M | 123k | 261k |
| Operating Income | -2.12M | -5.7M | -2.82M | -14.77M | -18.13M | -20.09M |
| Pre Tax Income | -2.15M | -5.72M | -2.85M | -14.79M | -18.05M | -19.03M |
| Net Income | -2.15M | -5.72M | -2.85M | -14.79M | -18.05M | -19.03M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.263 | -0.7 | -0.283 | -0.588 | -0.716 | -3.082 |
| EBIT | -2.12M | -5.7M | -2.82M | -14.77M | -18.13M | -20.09M |
| EBITDA | -2.12M | -5.7M | -2.82M | -14.77M | -18.12M | -19.91M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
